Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

4.2K
The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
4.2K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.1K
Overview
69.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

830
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
830
What is the Immune System?01:38

What is the Immune System?

112.1K
Overview
112.1K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

1.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cholesterol-dependent cytolysin promotes <i>Streptococcus</i> systemic spread and induces arachidonic acid accumulation-mediated lethality in a murine intraperitoneal infection model.

Infection and immunity·2026
Same author

IL-22 promotes genesis of small intestinal secretory cells that protect against cholera in mice.

Nature microbiology·2026
Same author

Remodeling of tRNA modification in Trypanosoma cruzi life forms.

PLoS pathogens·2026
Same author

Early-life Wnt4 expressing colon stromal cells orchestrate lifelong mucosal homeostasis via BMP-driven iNKT cell imprinting.

Nature communications·2026
Same author

A pro-carcinogenic bacterial toxin binds claudin-4 to cleave E-cadherin.

Nature·2026
Same author

IL-22 promotes genesis of small intestinal secretory cells that protect against cholera in mice.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jul 26, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K

Innate immune responses yield tissue-specific bottlenecks that scale with pathogen dose.

Karthik Hullahalli1, Katherine G Dailey1, Matthew K Waldor1

  • 1Department of Microbiology, Harvard Medical School, Boston, MA 02115; Division of Infectious Diseases, Brigham & Women's Hospital, Boston, MA 02115.

Biorxiv : the Preprint Server for Biology
|June 19, 2023
PubMed
Summary

Pathogen dose impacts immune barriers, revealing "dose scaling" where immune response effectiveness changes with bacterial load. This finding offers a new framework for understanding infection outcomes.

More Related Videos

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.7K

Related Experiment Videos

Last Updated: Jul 26, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.7K

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Disease

Background:

  • Pathogens must overcome host immune system bottlenecks to cause infection.
  • Infection bottlenecks determine disease outcome by restricting pathogen inoculum.
  • Understanding these bottlenecks is crucial for quantifying immune barrier effectiveness.

Approach:

  • Investigated *Escherichia coli* systemic infection models to identify infection bottlenecks.
  • Analyzed how bottleneck size changes with varying inoculum sizes.
  • Examined the role of pathogen dose on innate immune response efficacy.

Key Points:

  • Introduced the concept of "dose scaling" where innate immune response efficacy can increase or decrease with pathogen dose.
  • Demonstrated that dose scaling during *E. coli* infection is tissue-specific and dependent on the LPS receptor TLR4.
  • Showed that dose scaling can be mimicked using killed bacteria, indicating it relies on pathogen molecule sensing.

Conclusions:

  • Dose scaling quantitatively links innate immunity to infection bottlenecks.
  • This framework provides a novel understanding of how pathogen inoculum size influences infection outcomes.
  • Highlights the complex, dose-dependent nature of immune responses in infectious diseases.